PLYMOUTH MEETING, Pa., April 3, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced its novel therapy INO-3106 against the human papilloma virus type 6 (HPV 6) demonstrated ...

Please provide your email address to receive an email when new articles are posted on . Early post-therapy clearance of HPV appeared associated with improved survival among women with cervical cancer, ...

A multi-disciplinary task force convened by the American Society for Radiation Oncology has issued new guidelines for radiation therapy for HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) ...

Newswise — SAN DIEGO, September 25, 2017 – For certain patients with oropharyngeal cancer caused by the human papilloma virus (HPV), an aggressive reduction of radiation therapy after surgery may ...

BioNTech (NASDAQ:BNTX) shares declined 5% on Tuesday after the biotechnology company reported that its investigational mRNA ...

Patients with HPV-related oropharyngeal cancer who undergo surgery and are treated with chemotherapy, may be able to forgo significant radiation therapy without increasing the risk of their cancer ...

A potential new immune-based therapy to treat precancers in the cervix completely eliminated both the lesion and the underlying HPV infection in a third of women enrolled in a clinical trial. The shot ...

This article predates Brown Brothers Media’s ownership of Science Blog and has not been reviewed under our current editorial process. It is preserved as part of the publication’s archive. A potential ...

Once someone is infected with the human papillomavirus or HPV, there's been absolutely nothing that cleared the infection -- until now. Researchers say they've had success in phase two trials of a new ...

Kovina Therapeutics has received a $2.3 million Direct-to-Phase II Small Business Innovation Research award from the National ...